-
Vineet Laboratories Limited Approves Interim Dividend
At its board meeting held on February 13, 2023, the board of directors of Vineet Laboratories Limited recommended an interim dividend of INR 4.50 per share for the fiscal year 2022-23.
-
Vineet Laboratories Limited Reports Strong Q3 FY23 Results
Vineet Laboratories Limited reported a strong set of financial results for the third quarter ended December 31, 2022. The company's revenue from operations grew by 15.6% year-on-year to INR 1,234.5 crore.
-
Vineet Laboratories Limited Launches New Product for Chronic Kidney Disease
Vineet Laboratories Limited announced the launch of a new product, Renvela, for the treatment of chronic kidney disease. Renvela is a novel formulation that combines two existing drugs, sevelamer carbonate and phosphate binder.
-
Vineet Laboratories receives US FDA Approval for 23 DMFs
Mumbai, 21st January 2023: Vineet Laboratories Limited (VLL), a leading global manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates, announced today that it has received approval from the United States Food and Drug Administration (US FDA) for 23 Drug Master Files (DMFs). These DMFs are crucial for the commercialization of generic drug products in the US market and reflect VLL's commitment to quality and regulatory compliance.
-
Vineet Laboratories to Invest ₹200 Cr in New API Facility
Mumbai, 20th December 2022: Vineet Laboratories Limited (VLL), a leading global manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates, announced today that it will invest ₹200 crores in a new API manufacturing facility in Visakhapatnam, Andhra Pradesh.
-
Vineet Laboratories Launches New Sterile API Facility
Mumbai, 15th October 2022: Vineet Laboratories Limited (VLL), a leading global manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates, announced today the launch of its new sterile API manufacturing facility in Hyderabad, Telangana.
-
Vineet Laboratories bags $1 million order from Tanzania
Vineet Laboratories Limited, a leading manufacturer of veterinary formulations in India, has bagged an order worth $1 million from Tanzania. The order is for the supply of veterinary pharmaceuticals and animal health products, including vaccines, antibiotics, and antiparasitics.
-
Vineet Laboratories launches new animal health product
Vineet Laboratories Limited has launched a new animal health product, 'Vemedim'. Vemedim is a broad-spectrum antibiotic that is effective against a wide range of bacterial infections in animals.
-
Vineet Laboratories Limited Declares Dividend of Rs. 2.25 Per Equity Share
The Board of Directors of Vineet Laboratories Limited at its meeting held on 10th August, 2023, has declared a dividend of Rs. 2.25 per equity share having a face value of Rs. 10/- each for the financial year ended 31st March, 2023.
-
Vineet Laboratories Limited Reports Strong Financial Results for Q1 FY24
Vineet Laboratories Limited has reported strong financial results for the first quarter ended 30th June, 2023. The company's revenue from operations grew by 15% to Rs. 120 crore, while its net profit increased by 20% to Rs. 20 crore.
-
Vineet Laboratories Limited Launches New Product Line
Vineet Laboratories Limited has launched a new product line of pharmaceutical products. The new products include a range of antibiotics, anti-inflammatories, and cardiovascular drugs.
-
Vineet Laboratories Emerges as a Leading Manufacturer of Specialty Chemicals for Li-Ion Batteries
Vineet Laboratories Limited, a prominent player in the specialty chemicals industry, has established itself as a leading manufacturer of high-performance chemicals specifically designed for Lithium-ion (Li-ion) batteries.
-
Vineet Laboratories Strengthens Presence in Global Specialty Chemicals Market with Strategic Partnership
Vineet Laboratories Limited, a leading manufacturer of specialty chemicals, has announced a strategic partnership with a global leader in the specialty chemicals industry.
-
Vineet Laboratories Introduces Revolutionary Flame Retardant Solution for Enhanced Safety
Vineet Laboratories Limited, a leading provider of specialty chemicals, has developed and introduced a cutting-edge flame retardant solution that offers exceptional protection against fire hazards.
-
Vineet Labs receives ISO 17025 accreditation for its Pathology laboratory
The ISO 17025 accreditation is a globally recognized standard for testing and calibration laboratories, demonstrating the lab's competence in delivering accurate and reliable results.
-
Vineet Labs signs partnership with leading diagnostic company
The partnership will provide Vineet Labs with access to advanced diagnostic technologies and expertise, enhancing its services and offerings to patients.
-
Vineet Labs expands its network with new lab in Mumbai
The new lab in Mumbai will cater to the growing demand for laboratory services in the region and further strengthen Vineet Labs' presence in Western India.
